OUR COMPANY SOLUTIONS THERAPEUTIC EXPERTISE INSIGHTS HUB CAREERS NEWS INVESTORS INVESTIGATORS TRANSPARENCY SUPPLIERS CONTACT English Home COVID-19 Resource Center COVID-19 Resource Center Syneos Health Supports ACRO Statement on COVID-19 Vaccines The Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized tools and services to support the development of new pharmaceuticals, biologics and medical devices. We are proud of the role our member companies have played in the development of COVID vaccines, which have been supported by overwhelmingly positive and reliable data. Going forward, an increasing number of governments, healthcare systems, research sites and sponsors are requiring vaccination for the protection of clinical trial participants, medical and healthcare staff, and others. In keeping with our industry’s ongoing commitment to public health and patient safety, ACRO supports our member companies as they strongly recommend that their employees be fully vaccinated as quickly as possible, based on vaccine availability at the country and local level. Collaborating to Address the Challenge of COVID-19 We are here to listen, collaborate and be agile as we navigate this global health crisis together. During this time, we continue to look ahead and evolve our ways of working, ensuring that our processes, people and innovative technologies enable the continued development and delivery of medicines to patients worldwide. Explore this page to learn more about our preparedness, resources and perspectives on COVID-19. Corporate Updates During this challenging time we are committed to frequent, clear communication about the steps we are taking in response to the COVID-19 crisis, with the goal of ensuring that the vital work of delivering new therapies to patients continues. June 2021 | COVID-19 Business Continuity Planning Pulse May 2021 | COVID-19 Business Continuity Planning Pulse March-April 2021 | COVID-19 Business Continuity Planning Pulse February 2021 | COVID-19 Business Continuity Planning Pulse January 2021 | COVID-19 Business Continuity Planning Pulse December 2020 | COVID-19 Business Continuity Planning Pulse November 2020 | COVID-19 Business Continuity Planning Pulse October 2020 | COVID-19 Business Continuity Planning Pulse September 2020 | COVID-19 Business Continuity Planning Pulse August 2020 | COVID-19 Business Continuity Planning Pulse 6.1.2020 & 6.8.2020 | COVID-19 Business Continuity Planning Pulse 5.18.2020 & 5.25.2020 | COVID-19 Business Continuity Planning Pulse 4.27.2020 | COVID-19 Business Continuity Planning Pulse 4.20.2020 | COVID-19 Business Continuity Planning Pulse 4.13.2020 | COVID-19 Business Continuity Planning Pulse 4.7.2020 | COVID-19 Business Continuity Maps 4.6.2020 | COVID-19 Business Continuity Planning Pulse 4.3.2020 | Press Release: Syneos Health Responds to COVID-19 Public Health Challenge by Joining Call to Action to Activate Clinically-Qualified Healthcare Professionals 3.30.2020 | COVID-19 Business Continuity Planning Pulse 3.24.2020 | COVID-19 Business Continuity Planning Foundational Report 3.17.2020 | Our Connected Community: Syneos Health Response to COVID-19 Supporting Monitoring Continuity Keeping clinical trials running during a pandemic requires utilization of all the remote monitoring tools and technologies at our disposal to maintain data quality, support clinical sites and keep patients safe. Article: Clinical Operations in the Age of a Pandemic Webinar: Implementing Remote Clinical Trial Monitoring to Ensure Continuity of Trials and Data Preservation – While Keeping Patients Safe Unparalleled Product Development Expertise Clinical trials to test vaccines and treatments during a pandemic demand extreme speed in start-up, a rapid operational tempo and access to subjects in high-risk areas for the targeted disease. Getting these products to market requires an agile partner with deep therapeutic expertise, novel strategy and flawless execution. Fact Sheet: Accelerating Clinical Development to Address COVID-19 Fact Sheet: Flexible, Scalable Solutions to Solve Challenges Unique to COVID-19 Asset Commercialization Syneos Health Infectious Disease and Vaccine Capabilities COVID-19 Multimedia The Syneos Health Podcast Our Coronavirus Special Edition Podcast Series explores, from an operational standpoint, the impact of COVID-19 on the biopharmaceutical industry, the challenges for rapid R&D in an outbreak environment, and the opportunities to leverage technology and innovation to address these critical issues. Coronavirus Special Edition: The Personal Experience Coronavirus Special Edition: The Clinical Experience Coronavirus Special Edition: Virtual Clinical Trials Coronavirus Special Edition: Clinical Trials Through Pandemics Coronavirus Special Edition: Surviving the Ventilator Shortage Coronavirus Special Edition: The Leader's Experience Coronavirus Special Edition: Continuity in Clinical Trials For more perspectives on helpful strategies at this time – from virtual trials to crisis communications: Visit Our Insights Hub COVID-19 Special Initiative: Ventilator Initiative Task Force A critical shortage of mechanical ventilators is anticipated in many countries, including the United States, because of the COVID-19 pandemic. Recent FDA guidance provides for the use existing hospital BiPAP (bi-level positive airway pressure) machines on an emergency basis to spare mechanical ventilation if necessary. Syneos Health has launched the Ventilator Initiative Task Force as a platform for mobilizing awareness and action, and to support healthcare professionals with education, training and research. White Paper: Intubated BiPAP Use to Delay Mechanical Ventilation in COVID-19 Find more information and materials from our Ventilator Initiative here Related Links ACRO: Commitment to COVID-19 Collaboration Insights Hub: Our Perspectives to Help You Navigate COVID-19 World Health Organization A Message from CEO Alistair Macdonald Interested in Syneos Health? Get In Touch Connect Syneos Health Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 28,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Contact Us Corporate Headquarters 1030 Sync Street Morrisville, NC 27560 Phone: +1 919 876 9300 Fax: +1 919 876 9360 Toll-Free: +1 866 462 7373 Solutions Therapeutic Expertise Brand Directory Careers Study Participants Media Business Ethics Helpline Events Transparency © 2021 Syneos Health. All Rights Reserved. Terms Of Use Privacy Notice Privacy Shield Online Tracking Opt-Out About Cookies On This Site We store your consent for 6 months with 19 partners for Ad Exchange, Ad Network, Ad Server, Analytics Provider, Business Intelligence, Data Aggregator/Supplier, Mobile, Other, Publisher, Social Media, Tag Manager. Read our policy Accept All Manage Settings Show PurposesShow Vendors